Results 291 to 300 of about 155,033 (349)

Ultraviolet therapy in lupus

Lupus, 2001
This review examines the use of ultraviolet (UV) therapy in lupus erythematosus (LE), a disorder usually associated with abnormally increased photosensitivity. In addition to the abnormal cutaneous response to ultraviolet radiation (UVR) exposure, photo-aggravation of systemic disease activity in systemic LE (SLE) may also occur.
Millard, T P, Hawk, J L M
openaire   +2 more sources

Status of ultraviolet A dosimetry in methoxsalen plus ultraviolet A therapy

Journal of the American Academy of Dermatology, 1986
The carcinogenic risk of methoxsalen plus ultraviolet A treatment (PUVA) is almost certainly related to the cumulative UVA exposure dose. A reliable estimate of UVA dose is a major component, therefore, in determining the long-term safety of this treatment modality.
B L, Diffey, R, Roelandts
openaire   +2 more sources

Ultraviolet Therapy for Psoriasis

2014
Total-body ultraviolet therapy (UV) for moderate-to-severe psoriasis consists of narrowband and broadband-UVB, psoralen plus UVA (PUVA – where psoralen can be ingested orally or applied topically), inpatient phototherapy (i.e. Goeckerman Therapy, Ingram therapy), non-office-based phototherapy (i.e.
Tien V. Nguyen, John Y. M. Koo
openaire   +1 more source

Ultraviolet and laser therapy

2008
Natural sunlight’s beneficial effect on psoriasis has been long known. This observation led over the past century to the utilization of artificial light sources for the treatment of psoriasis. For over seven decades, phototherapy using artificial ultraviolet light has been an established standard in the treatment of psoriasis.
Rahat S. Azfar, Abby S. Van Voorhees
openaire   +1 more source

Ultraviolet Skin Marking in Radiation Therapy

The British Journal of Radiology, 1961
The purpose of this communication is to bring to the attention of radiologists a method of marking skin portals in radiation therapy aesthetically. The common practice of using visible, indelible inks, surface dyes and by tattoo, presents a problem to most patients who become self-conscious when markings are on exposed parts of the body or distasteful ...
openaire   +2 more sources

Ultraviolet Therapy of Atopic Eczema

1997
Recent results from a pilot study have suggested that irradiation of patients with high doses of ultraviolet A1 radiation (UVA-1; 340–400 nm) may be effectively used as a monotherapy in the management of severe exacerbation of atopic dermatitis [1]. This assumption has recently been confirmed in a multicenter trial [2].
J. Krutman, M. Grewe
openaire   +1 more source

Ultraviolet Light Therapy for Psoriasis

Archives of Dermatology, 1975
To the Editor.— In the April 1974 issue of theArchives, Drs. Stern and Kihiczak reported the results of their attempts to determine the action spectrum of ultraviolet light-induced clearing of psoriasis (109:502, 1974). Using a xenon arc solar simulator and a cold quartz lamp, the authors compared the clearing of psoriatic plaques that occurred after ...
openaire   +1 more source

ULTRAVIOLET RAY THERAPY IN DERMATOLOGY

Archives of Dermatology, 1924
Twenty-seven years have elapsed since Finsen introduced ultraviolet ray therapy in the treatment of lupus vulgaris and other cutaneous affections. It would seem reasonable to believe that in view of the many experiments since that time in the application of these rays by numerous apparently qualified observers, there would be a reasonable unanimity of ...
openaire   +1 more source

CLINICAL ASPECTS OF ULTRAVIOLET THERAPY

Journal of the American Medical Association, 1938
To write another article on the subject of ultraviolet therapy would seem, at first sight, to be quite inexcusable. There are few subjects on which more papers have been published, few subjects more ably covered in articles of review, and, one might add, no subject more capable of reducing to utter despair an author faced with the necessity of saying ...
openaire   +1 more source

Ultraviolet Light Therapy for Psoriasis-Reply

Archives of Dermatology, 1975
To the Editor.— I want to thank Drs. Tanenbaum, Pathak, and Parrish for their comments. There are, however, certain statements with which I take issue. In the first place, the definition of minimal erythemal dose (MED) refers to erythemogenic irradiation, not to the UVA spectrum.
openaire   +1 more source